1. WHO Weekly epidemiological report 2016; 22 (91): 285-296.
2. Tabbabi A. Review of Leishmaniasis in the Middle East and North Africa. Afri Health Sci 2019; 19: 1329-1337.
3. Tunalı V, Özbilgin A. Knock, knock, knocking on europe’s door: Threat of Leishmaniasisin europe with a focus on Turkey. CRPVBD 2023; 4:100150.
4. Unat EK, Leyişmanyazların tarihçesi. In: Leyişmanyaz, Yaşarol Ş, ed. Türkiye Parazitoloji Derneği Yayınları, s. 1-10; 1981.
5. Lima ID, Queiroz JW, Lacerda HG. et al. Leishmania infantum chagasi in Northeastern Brazil: asymptomatic infection at the urban perimeter. Am J Trop Med Hyg 2012; 86: 99-107.
6. Alemayehu B, Alemayehu M. Leishmaniasis: A review on parasite, vector and reservoir host. Health Sci J 2017; 11: 519.
7. Karakuş M, Öktem MA, Sözen M. et al. First molecular detection and identification of Leishmania species in small wild rodents from Turkey. Parasitology 2020; 147:1088-1093.
8. Aksulu A, Bilgiç HB, Karagenç T, Bakırcı s. Seroprevalence and molecular detection of Leishmania spp. in cats of West Aegean Region, Turkey. Vet Parasitol: Reg Stud Rep 2021; 24: 100573.
9. Kumar A, Singh VK, Tiwari R. et al. Post kala-azar dermal Leishmaniasis in the Indian sub-continent: challenges and strategies for elimination. Front Immunol 2023; 14:1236952.
10. https://www.who.int/data/gho/map-gallery-search-results
11. Akhoundi M, Downing T, Votypka J. et al. Leishmania infections: Molecular targets and diagnosis. Mol Aspects Med 2017; 57:1-29.
12. Silva FA, Costa DA, Silva BHM. et al. Identification of phlebotomine sand fly (Diptera: Psychodidae) in Atlantic forest fragments and their dispersal to urban area. An Acad Bras Cienc 2023;
95: e20191596.
13. Gillespie RD, Mbow ML, Titus RG. The immunomodulatory factors of bloodfeeding arthropod saliva. Parasite Immunol 2000; 22: 319-331.
14. Koliou MG, Antoniou Y, Antoniou M, Christodoulou V, Mazeris A, Soteriades E.S. A cluster of four cases of cutaneous Leishmaniasis by Leishmania donovani in Cyprus: a case series. J Med
Case Rep 2014; 8: 354.
15. Talmi-Frank D, Jaffe CL, Nasereddin A. Et al. Leishmania tropica in rock Hyraxes (Procavia capensis) in a focus of human cutaneous leishmaniasis. Am J Trop Med Hyg 2010; 82: 814-818.
16. Abranches P. Reservoirs of visceral Leishmaniasis (Ed. DT Hart) Plenum Publishing Corporation: 61-70, 1989.
17. Gradoni L. Canine reservoir of zoonotic visceral leishmaniasis in the Mediterranean area: Epidemiology and control. Inf Circ WHO Mediterr Zoon Control Cent; 37: 12-13, 1995.
18. Arce A, Estirado A, Ordobas M. et al. Re-emergence of Leishmaniasis in Spain: community outbreak in Madrid Spain, 2009 to 2012. Euro Surveill 2013; 18: 20546.
19. Ozensoy S, Ozbel Y, Turgay N. et al. Serodiagnosis and epidemiology of visceral Leishmaniasis in Turkey. Am J Trop Med Hyg 1998; 59: 363-369.
20. Dujardin JC, Campino L, Canavate C. et al. Spread of vector borne diseases and neglect of Leyişmanyaz, Europe. Emerg Infect Dis 2008; 14: 13-18.
21. Christodoulou V, Antoniou M, Ntais P. et al. Re-emergence of visceral and cutaneous leishmaniasis in the Greek Islands of Crete. Vector Borne Zoonotic Dis 2012; 12: 2014-22.
22. Özbel Y, Töz S, Munoz C. et al. The current epidemiology of leishmaniasis in Turkey, Azerbeijan and Georgia and implications for disease emergence in European countries. Zoonoses Public
Health 2022; 69:395-407.
23. Serin MS, Daglioglu K, Bagirova M. et al. Rapid diagnosis and genotyping of Leishmania isolates from cutaneous and visceral leishmaniasis by microcapillary cultivation and polymerase chain
reaction-restriction fragment length polymorphism of miniexon region. Diagn Microbiol Infect Dis 2005; 53: 209-14.
24. Özbilgin A, Harman M, Karakuş M. et al. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey. Acta Trop 2017; 173:90-96.
25. Özbilgin A, Töz S, Harman M. et al. The current clinical and geographical situation of cutaneous leishmaniasis based on species identification in Turkey. Acta Trop 2019; 190:59-67.
26. Özbilgin A, Tunalı V, Çavuş İ. et al. Visceral leishmaniasis caused by Leishmania tropica. Acta Parasitol 2023; 68: 699-704.
27. Kurşun E, Turunç T, Demiroğlu Y.Z. et al. Evaluation of fourteen adult cases with visceral leishmaniasis. Mikrobiyol Bul 2013; 47(3):500-6.
28. Özbel Y, Turgay N, Ozensoy S. et al. Epidemiology, diagnosis and control of leishmaniasis in the Mediterranean region. Ann Trop Med Parasitol 1995; 89(Suppl.1):89-93.
29. Arserim SK, Mermer A, Özbel Y. Fauna, seasonal activity and altitudinal distribution of Phlebotomine sand flies (Diptera: Psychodidae) in leishmaniasis endemic area, Aydın mountains and
surroundings in western Turkey. T Parazitol Derg, 2022; 46: 60-71.
30. Ok ÜZ, Balcıoğlu İC, Taylan Özkan A. et al. Leishmaniasis in Turkey. Acta Tropica; 84: 43, 2002.
31. WHO/LEISH/96.40. 1996. Manual on Visceral Leishmaniosis Control. WHO Division of Control of Tropical Diseases, Geneva. https://www-who-int.translate.goog/publications/i/item/
WHO-LEISH-96.40?_x_tr_sl=en&_x_tr_tl=tr&_x_tr_hl=tr&_x_tr_pto=sc
32. Markell EK, John DT, Krotoski WA. Markell and Voge’s Medical Protozoology. 8th Edition, WB Saunders Company: p.123-188, 1999.
33. WHO, The fight against leishmaniasis. Report of a WHO committee experts. Technical Genes No. 793. Geneva, Switzerland. 1990.
34. Unat 1981. Leyişmanyazların tarihçesi. Leishmaniosis, Yaşarol Ş. (ed).1-10. 1981.
35. Gurel MS, Ulukanligil M, Ozbilge H. Cutaneous leishmaniasis in Sanliurfa: epidemiologic and clinical features of the last four years (1997–2000). Int J Dermatol 2002; 41: 32–37.
36. Gürel MS, Yeşilova Y, Ölgen MK. Türkiye’de kutanöz leyişmanyazın durumu. T Parazitol Derg 2012; 36:121-129.
37. Özbel Y, Ölgen MK, Kitapçıoğlu G, ve ark. Türkiye’de şark çıbanı olgularının dağılımı. Özbel Y, Töz S, Kitapçıoğlu G (Eds). ISBN: 978-605-87556-9-7, 2019; s.15-30.
38. Yıldız Zeyrek F, Gürses G, Uluca N, Yentür Doni N, Toprak Ş, Yeşilova Y, Çulha G. Is the agent of Cutaneous Leishmaniasis in Sanliurfa changing? First cases of Leishmania major. Turkish J
of Parasitol. 2014; 38(49):270-74.
39. Yıldız Zeyrek F, Töz S, Uluca N, Doni N, Toprak Ş, Özbel Y. Cutaneous Leishmaniasis Cases Caused by Leishmania infantum in Şanlıurfa Province, Turkey. Mikrobiyol Bul. 2020; 54(4):647-
656.
40. Harman M. Şark çıbanı kliniği. Özbel Y, Töz S, Kitapçıoğlu G (Eds). ISBN: 978-605-87556-9-7, 2019; s.203-206.
41. Hepburn NC. Cutaneous Leishmaniasis: An Overview. J Postgrad Med 2003; 49:50-54.
42. Uzun S, Gürel MS, Durdu M. et al. Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey. Int J Dermatol 2018; 57: 973-982.
43. Töz S, Özbel Y. Paraziter enfeksiyonların tanı ve epidemiyolojisinde moleküler yöntemlerin kullanımı. Durmaz R, Eser Ö, Otlu B (Eds.) Akademik Kitabevi Yayınları ISBN 978-625-8259-12-4.
S.571-588.
44. Çulha G, Kaya T, Doğramacı AÇ, Hatay’da göç öncesi ve sonrası saptanan kutanöz leishmaniasis olgularının gerçek zamanlı polimeraz zincir reaksiyonu ile genotiplendirilmesi. Türkiye
Parazitol Derg 2020; 44(1):48-51.
45. Doni NY, Gurses G, Dikme R, Aksoy M, Yildiz Zeyrek F, Simsek Z, et al. Cutaneous leishmaniasis due to three Leishmania species among Syrian refugees in Sanliurfa, Southeastern Turkey.
Acta Parasitol 2020; 65: 936-948.
46. Hajjaran H, Mahdi M, Mohebali M, et al. Detection and molecular identification of Leishmania RNA virus (LRV) in Iranian Leishmania species. Arch Virol 2016; 161: 3385–90.
47. Nalçacı M, Karakuş M, Yılmaz B, Demir S, Özbilgin A, Özbel Y, et al. Detection of Leishmania RNA virüs in Leishmania species from Turkey. Trans R Soc Trop Med Hyg 2019; 113: 410-417.
48. Yildiz Zeyrek F., M. Korkmaz, Y. Özbel. Serodiagnosis Of Anthroponotic Cutaneous Leishmaniasis (ACL) Caused By Leishmania Tropica İn Sanliurfa Province, Turkey, Where ACL İs Highly
Endemic. Clinical And Vaccine Immunology, 2007; 14(11): 1409-1415.
49. Murray HW. Clinical and Experimental Advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother 2001; 45: 2185–2197.
50. Gradoni L, Lopez-Velez R, Mokni M. WHO Manuel on case management and surveillance of the leishmaniases in the WHO European region. WHO 2017.
51. Gradoni L, Gaeta GB, Pellizzer G. et al. Mediterranean visceral leishmaniasis in pregnancy. Scand J Infect Dis 1994; 26: 627-9.
52. Falcoff E, Gimenez LA, Bernabo JG. Et al. Interferon gamma as an immunological strategy for the treatment of human leishmaniasis. Medicina (B Aires) 1994; 54: 265-71.
53. Asilian A, Jalayer T, Nilforooshzadeh M. et al. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of
Iran. Bulletin WHO 2003; 81:353-359.
54. Uzun S, Uslular C, Yucel A. et al. Cutaneous leishmaniasis: evaluation of 3074 cases in the Cukurova region of Turkey. Br J Derm 1999; 140:347-50